27.40
-1.72
(-5.91%)
As of 2:52:25 PM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Yat-Gai Au | Founder, Chairman & CEO | -- | -- | 1973 |
| Ms. Michelle Chan | Financial Controller & Principal Financial Officer | -- | -- | -- |
| Mr. Wai Hong Chung | COO, Chief Strategy Officer & Director | 245.64k | -- | 1977 |
| Ms. Antonia Assang | Senior Vice President of Project Management | -- | -- | -- |
| Mr. Yat-Pui Au | Chief Business Officer | -- | -- | 1974 |
Regencell Bioscience Holdings Limited
Chinachem Leighton Plaza
9th Floor 29 Leighton Road
Causeway Bay
Hong Kong
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 12
Description
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Corporate Governance
Regencell Bioscience Holdings Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Related Tickers
SXTC China SXT Pharmaceuticals, Inc.
1.1200
-48.15%
ZYBT Zhengye Biotechnology Holding Limited
8.00
-20.48%
UPC Universe Pharmaceuticals INC
4.3408
+29.19%
PRFX PainReform Ltd.
2.1200
+3.41%
QNTM Quantum BioPharma Ltd.
6.10
-3.16%
IRWD Ironwood Pharmaceuticals, Inc.
0.7030
-3.26%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.2398
-5.40%
RDHL RedHill Biopharma Ltd.
2.2099
-2.22%
ORGO Organogenesis Holdings Inc.
4.2050
-0.36%
PTPI Petros Pharmaceuticals, Inc.
0.0419
+2.20%